Lin Lin
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 9
- Cytokine Signaling Pathways and Interactions 7
- Metal complexes synthesis and properties 6
- Peptidase Inhibition and Analysis 6
- Cancer Research top 10%
- Emergency Medical Services top 5%
- Central Venous Catheters and Hemodialysis 11
-
- Cardiovascular Health and Disease Prevention 7
- Nephrology top 10%
-
- Lung Cancer Treatments and Mutations 9
- Vascular Procedures and Complications 7
- Co-authors
- Chih‐Cheng WuDavid G. BeerMu‐Yang HsiehGuoan ChenJules LinAndrew C. ChangZhuwen WangDafydd G. Thomas
- Journals
- Cancer Management and Research (3 papers)Journal of Vascular Surgery (3 papers)Journal of the American College of Cardiology (3 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Lin Lin
127 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 119
- Oncology 582
- Cancer Research 224
- Emergency Medical Services 100
- Cardiology and Cardiovascular Medicine 282
- Nephrology 82
Countries citing papers authored by Lin Lin
This map shows the geographic impact of Lin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Lin more than expected).
Fields of papers citing papers by Lin Lin
This network shows the impact of papers produced by Lin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Lin. The network helps show where Lin Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 24 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 29 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 27 | |
| 9 | Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial | 2020 | 1 |
| 10 | 2020 | 8 | |
| 11 | 2019 | 2 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 1 | |
| 14 | 2017 | 14 | |
| 15 | 2014 | 3 | |
| 16 | 2012 | 15 | |
| 17 | The Application Comparison between PICC and VPA for Mammary Cancer Patients in Chemotherapy | 2011 | 0 |
| 18 | 2010 | 85 | |
| 19 | Clinical characteristics of Han and Uygur child-bearing patients with polycystic ovary syndrome in Xinjiang | 2010 | 1 |
| 20 | The predicting value of small airway diseases for asthma in patients with chronic cough | 2007 | 0 |
About Lin Lin
Lin Lin is a scholar working on Oncology, Emergency Medical Services, Internal Medicine, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 140 papers that have together received 1.6k indexed citations. Recurring topics across this work include Central Venous Catheters and Hemodialysis (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (9 papers), Cytokine Signaling Pathways and Interactions (7 papers), Vascular Procedures and Complications (7 papers), Cardiovascular Health and Disease Prevention (7 papers), Metal complexes synthesis and properties (6 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Oncology (582 citations), Cancer Research (224 citations), Emergency Medical Services (100 citations), Cardiology and Cardiovascular Medicine (282 citations) and Nephrology (82 citations). Lin Lin has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Chih‐Cheng Wu, David G. Beer, Mu‐Yang Hsieh, Guoan Chen, Jules Lin, Andrew C. Chang, Zhuwen Wang, Dafydd G. Thomas, Diane M. Simeone and Sunitha Nagrath. Their work appears in journals such as Cancer Management and Research, Journal of Vascular Surgery, Journal of the American College of Cardiology, Journal of Cellular and Molecular Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.